We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » China to Allow Biosimilar Reference Products Approved Elsewhere
China to Allow Biosimilar Reference Products Approved Elsewhere
China is opening its market to biosimilars, issuing the country’s first-ever guideline on the technical review of the products and criteria for establishing biosimilarity.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor